These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2835796)
1. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes. Wiik P Regul Pept; 1988 Apr; 20(4):323-33. PubMed ID: 2835796 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids upregulate the high affinity receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes in vitro. Wiik P Regul Pept; 1991 Jul; 35(1):19-30. PubMed ID: 1656488 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides. Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008 [TBL] [Abstract][Full Text] [Related]
4. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
6. Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini. Zhou ZC; Gardner JD; Jensen RT Peptides; 1987; 8(4):633-7. PubMed ID: 2819833 [TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase. Besson J; Malassiné A; Ferré F Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor. Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842 [TBL] [Abstract][Full Text] [Related]
9. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Turner JT; Jones SB; Bylund DB Peptides; 1986; 7(5):849-54. PubMed ID: 3025826 [TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448 [TBL] [Abstract][Full Text] [Related]
11. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
12. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504 [TBL] [Abstract][Full Text] [Related]
13. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase. Prieto JC; Guerrero JM; de Miguel C; Goberna R Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963 [TBL] [Abstract][Full Text] [Related]
14. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375 [TBL] [Abstract][Full Text] [Related]
15. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites. Martin JM; Luis J; Marvaldi J; Pichon J; Pic P Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331 [TBL] [Abstract][Full Text] [Related]
16. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages. Pozo D; Guerrero JM; Calvo JR Peptides; 1995; 16(2):313-8. PubMed ID: 7784261 [TBL] [Abstract][Full Text] [Related]
17. Receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes are upregulated during prolonged strain and energy deficiency. Wiik P; Opstad PK; Knardahl S; Bøyum A Peptides; 1988; 9(1):181-6. PubMed ID: 2834700 [TBL] [Abstract][Full Text] [Related]
18. VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line. Robberecht P; De Neef P; Waelbroeck M; Tastenoy M; Christophe J Peptides; 1989; 10(2):441-6. PubMed ID: 2474155 [TBL] [Abstract][Full Text] [Related]
19. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Christophe J; Waelbroeck M; Chatelain P; Robberecht P Peptides; 1984; 5(2):341-53. PubMed ID: 6089134 [TBL] [Abstract][Full Text] [Related]